A new micronized formulation of 2-methoxyestradiol- bis -sulfamate (STX140) is therapeutically potent against breast cancer

Paul A. Foster, Simon P. Newman, Mathew P. Leese, Sonia Bernetiere, Christian Diolez, Jose Camara, Beatrice Hacher, Marie-Madeleine Baronnet, Tauhid Ali, Barry V. L. Potter, Michael J. Reed, Atul Purohit

Research output: Contribution to journalArticle

11 Citations (Scopus)
Original languageEnglish
Pages (from-to)577-581
JournalAnticancer Research
Volume28
Issue number2A
Publication statusPublished - 2008

Cite this

Foster, P. A., Newman, S. P., Leese, M. P., Bernetiere, S., Diolez, C., Camara, J., Hacher, B., Baronnet, M-M., Ali, T., Potter, B. V. L., Reed, M. J., & Purohit, A. (2008). A new micronized formulation of 2-methoxyestradiol- bis -sulfamate (STX140) is therapeutically potent against breast cancer. Anticancer Research, 28(2A), 577-581.